JY
CLOV icon

Jeff Yass’s Clover Health Investments CLOV Stock Holding History

Jeff Yass’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$972K Sell
185,450
-713,107
-79% -$2.42M ﹤0.01% 8274
2026
Q1 		$1.58M Sell
898,557
-1,426,696
-61% -$3.09M ﹤0.01% 6728
2025
Q4 		$5.46M Sell
2,325,253
-376,643
-14% -$1.03M ﹤0.01% 3879
2025
Q3 		$8.27M Sell
2,701,896
-289,857
-10% -$828K ﹤0.01% 3288
2025
Q2 		$8.35M Buy
2,991,753
+829,541
+38% +$2.73M ﹤0.01% 3106
2025
Q1 		$7.76M Sell
2,162,212
-577,466
-21% -$2.32M ﹤0.01% 2879
2024
Q4 		$8.63M Buy
2,739,678
+860,480
+46% +$3.08M ﹤0.01% 2839
2024
Q3 		$5.3M Sell
1,879,198
-529,780
-22% -$1.21M ﹤0.01% 3503
2024
Q2 		$2.96M Sell
2,408,978
-1,212,047
-33% -$1.09M ﹤0.01% 4331
2024
Q1 		$2.88M Sell
3,621,025
-53,449
-1% -$48.6K ﹤0.01% 4604
2023
Q4 		$3.5M Buy
3,674,474
+2,200,692
+149% +$2.16M ﹤0.01% 4321
2023
Q3 		$1.59M Sell
1,473,782
-927,891
-39% -$1.1M ﹤0.01% 5605
2023
Q2 		$2.15M Buy
2,401,673
+1,021,849
+74% +$906K ﹤0.01% 5001
2023
Q1 		$1.17M Sell
1,379,824
-487,848
-26% -$534K ﹤0.01% 6415
2022
Q4 		$1.74M Sell
1,867,672
-622,477
-25% -$831K ﹤0.01% 4982
2022
Q3 		$4.23M Buy
2,490,149
+5,561
+0.2% +$14.6K ﹤0.01% 3423
2022
Q2 		$5.32M Sell
2,484,588
-4,830,074
-66% -$12.8M ﹤0.01% 3081
2022
Q1 		$26M Buy
7,314,662
+2,262,376
+45% +$6.56M ﹤0.01% 1463
2021
Q4 		$18.8M Sell
5,052,286
-1,045,759
-17% -$6.41M ﹤0.01% 1920
2021
Q3 		$45.1M Buy
6,098,045
+3,165,985
+108% +$27.1M 0.01% 1235
2021
Q2 		$39.1M Buy
2,932,060
+761,555
+35% +$7.48M 0.01% 1387
2021
Q1 		$16.4M Buy
2,170,505
+22,882
+1% +$258K ﹤0.01% 2125
2020
Q4 		$36M Buy
+2,147,623
New +$23.9M 0.01% 1229

Other funds holding CLOV

California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Jeff Yass's CLOV Position: Q2 2026 in Review

Jeff Yass reduced its Clover Health Investments (CLOV) stake by 79% in Q2 2026, selling an estimated $2.42M and leaving 185,450 shares worth $972K. The position accounts for ﹤0.01% of the portfolio, ranked #8274.

Jeff Yass first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $45.1M in Q3 2021. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Jeff Yass held 185,450 shares of Clover Health Investments worth $972K as of Q2 2026.
  • Jeff Yass sold 713,107 Clover Health Investments shares in Q2 2026, an estimated $2.42M.
  • Clover Health Investments made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8274 holding.
  • Jeff Yass first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Jeff Yass's Clover Health Investments position peaked at $45.1M in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.